Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF MICHIGAN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1817-01-01

Employees: 10K

Market Cap: -

Website: http://www.umich.edu

Clinical Trials

A Randomized Trial of GM-CSF in Patients With ALI/ARDS

Phase 2

Completed

Conditions: Respiratory Distress Syndrome, Adult

Interventions: Drug: GM-CSF
Drug: Placebo

First Posted Date: 2005-09-20

Last Posted Date: 2015-12-29

Lead Sponsor: University of Michigan

Target Recruit Count: 132

Registration Number: NCT00201409

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Effects of Anticipation of Pain Relief on Brain Mechanisms

Not Applicable

Completed

Conditions: Pain

Interventions: Procedure: Hypertonic saline
Procedure: Isotonic saline

First Posted Date: 2005-09-20

Last Posted Date: 2017-03-24

Lead Sponsor: University of Michigan

Target Recruit Count: 60

Registration Number: NCT00200876

Locations: 🇺🇸
University of Michigan Medical Center, Ann Arbor, Michigan, United States

Pharmacokinetics of Mmf and Valganciclovir

Phase 4

Completed

Conditions: Heart Transplant Recipient
Kidney Transplant Recipient

First Posted Date: 2005-09-16

Last Posted Date: 2016-05-25

Lead Sponsor: University of Michigan

Target Recruit Count: 16

Registration Number: NCT00189150

Locations: 🇺🇸
University of Michigan Hospital, Ann Arbor, Michigan, United States

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

Phase 1

Completed

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Drug: Tetrathiomolybdate

First Posted Date: 2005-09-16

Last Posted Date: 2013-02-06

Lead Sponsor: University of Michigan

Target Recruit Count: 23

Registration Number: NCT00189176

Locations: 🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States

Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention

Phase 2

Completed

Conditions: Systemic Lupus Erythematosus

First Posted Date: 2005-09-16

Last Posted Date: 2016-05-18

Lead Sponsor: University of Michigan

Target Recruit Count: 13

Registration Number: NCT00189124

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Pioglitazone in Hepatitis C

Phase 4

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: Placebo Oral Tablet
Drug: Pioglitazone

First Posted Date: 2005-09-16

Last Posted Date: 2016-12-16

Lead Sponsor: University of Michigan

Target Recruit Count: 40

Registration Number: NCT00189163

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

Phase 2

Completed

Conditions: Kidney Transplantation
End Stage Renal Disease

Interventions: Drug: Sirolimus

First Posted Date: 2005-09-16

Last Posted Date: 2018-03-27

Lead Sponsor: University of Michigan

Target Recruit Count: 49

Registration Number: NCT00189202

Locations: 🇺🇸
University of Michigan Health Center, Ann Arbor, Michigan, United States

Stepping Up to Health: Feedback to Promote Physical Activity in Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

First Posted Date: 2005-09-08

Last Posted Date: 2009-12-09

Lead Sponsor: University of Michigan

Target Recruit Count: 40

Registration Number: NCT00151021

Locations: 🇺🇸
University of Michigan, Department of Family Medicine, Ann Arbor, Michigan, United States

Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia

Phase 1

Completed

Conditions: Fibromyalgia

Interventions: Other: Sham treatment
Device: Acupuncture

First Posted Date: 2005-09-02

Last Posted Date: 2015-04-13

Lead Sponsor: University of Michigan

Target Recruit Count: 46

Registration Number: NCT00142597

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

Phase 1

Terminated

Conditions: Psoriasis
Dermatoses
Atopic Dermatitis
Alopecia
Urticaria
Stretch Marks
Mycosis Fungoides

Interventions: Procedure: UVA1 Irradiation
Procedure: UVB Irradiation

First Posted Date: 2005-08-11

Last Posted Date: 2015-05-22

Lead Sponsor: University of Michigan

Target Recruit Count: 28

Registration Number: NCT00129415

Locations: 🇺🇸
University of Michigan Department of Dermatology, Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy